Cooper W O, Hickson G B
Division of General Pediatrics, Vanderbilt Children's Hospital, Vanderbilt University Medical Center, Suite 5028, Medical Center East, Nashville, TN 37232-8555, USA.
Arch Pediatr Adolesc Med. 2001 Oct;155(10):1111-5. doi: 10.1001/archpedi.155.10.1111.
To identify predictors of corticosteroid prescription filling following an emergency department (ED) visit or a hospitalization for asthma.
A retrospective cohort study.
Tennessee children (defined as those aged 2-17 years in this study) covered by Medicaid were included in the cohort if they had an ED visit or a hospitalization for asthma between July 1, 1995, and December 31, 1997.
Prescriptions filled in the child's name for an oral corticosteroid within 7 days of the latest ED visit or hospitalization for asthma.
Of 6035 Tennessee children covered by Medicaid with an ED visit for asthma and of 2102 covered by Medicaid with a hospitalization for asthma during the study period, less than half (44.8% following an ED visit and 55.5% following a hospitalization) had prescriptions filled for oral corticosteroids within 7 days. Factors independently predicting a child's not having an oral corticosteroid prescription filled included older age, black race, and residence in rural regions of the state. Conversely, children with oral corticosteroid prescriptions in the previous 6 months were more likely to have oral corticosteroid prescriptions filled following an ED visit for asthma, and children with more than 3 beta-agonist prescriptions in the previous 6 months were more likely to have oral corticosteroid prescriptions filled following a hospitalization for asthma.
Overall, fewer than half of Tennessee children covered by Medicaid had an oral corticosteroid prescription filled following an ED visit or a hospitalization for asthma. Age, race, and county of residence predicted failure to have a prescription filled. Further study is needed to determine whether variations in corticosteroid prescription filling relate to physician practice, family behavior, or both.
确定在急诊科就诊或因哮喘住院后使用皮质类固醇药物处方配药的预测因素。
一项回顾性队列研究。
纳入队列的是田纳西州医疗补助覆盖的儿童(本研究中定义为年龄在2至17岁),他们在1995年7月1日至1997年12月31日期间因哮喘在急诊科就诊或住院。
在最近一次因哮喘在急诊科就诊或住院后7天内以儿童名义开具的口服皮质类固醇药物处方。
在研究期间,田纳西州6035名因哮喘在急诊科就诊的医疗补助覆盖儿童以及2102名因哮喘住院的医疗补助覆盖儿童中,不到一半(急诊科就诊后为44.8%,住院后为55.5%)在7天内开具了口服皮质类固醇药物处方。独立预测儿童未开具口服皮质类固醇药物处方的因素包括年龄较大、黑人种族以及居住在该州农村地区。相反,在过去6个月内有口服皮质类固醇药物处方的儿童在因哮喘在急诊科就诊后更有可能开具口服皮质类固醇药物处方,而在过去6个月内有超过3张β受体激动剂处方的儿童在因哮喘住院后更有可能开具口服皮质类固醇药物处方。
总体而言,田纳西州医疗补助覆盖的儿童中,不到一半在因哮喘在急诊科就诊或住院后开具了口服皮质类固醇药物处方。年龄、种族和居住县可预测未开具处方的情况。需要进一步研究以确定皮质类固醇药物处方配药的差异是否与医生的做法、家庭行为或两者都有关。